nimustine has been researched along with Pancreatic Neoplasms in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kakizaki, K; Matsuno, S; Sasaki, K; Sato, T | 1 |
| Abe, M; Ichiba, K; Kuraishi, Y; Meguro, S; Mikouchi, S; Yoda, T | 1 |
2 other study(ies) available for nimustine and Pancreatic Neoplasms
| Article | Year |
|---|---|
[Pancreatic and biliary excretion of 1-(4-amino-2-methyl-5-pyrimidinyl) methyl-3-(2-chloroethyl)-3-nitrosourea hydrochloride (ACNU) in man].
Topics: Adult; Antineoplastic Agents; Bile; Carcinoma, Papillary; Humans; Male; Middle Aged; Nimustine; Nitrosourea Compounds; Pancreatic Juice; Pancreatic Neoplasms | 1983 |
Combination chemotherapy with 5-FU 1-(aminomethyl)-3-(2-chloroethyl)-3-nitrosourea (ACNU), and mitomycin (FUM) for carcinoma of the pancreas.
Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Drug Therapy, Combination; Female; Fluorouracil; Humans; Male; Methotrexate; Middle Aged; Mitomycins; Neoplasm Metastasis; Nimustine; Nitrosourea Compounds; Pancreatic Neoplasms | 1982 |